QA: Rebus Holdings Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001421204_2022_Rebus_Holdings_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
warning Excluding company: variable exceeds outlier threshold pre-agg {'variable': 'Expenses', 'value': 664000, 'size_variable': 'Assets', 'size_value': 5000, 'ratio': 132.8, 'threshold': 20}

Graph

Absolute values for 0001421204, Rebus Holdings Inc

  xvar xval
0 AssetsCurrent 715,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 5,627,000
5 LiabilitiesNoncurrent 110,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 576,494
9 ResearchAndDevelopmentExpense 451,029
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 3,862,118
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 715,000
1 Liabilities 5,737,000
2 Expenses 1,027,523
3 Revenues 0
4 StockholdersEquity -5,022,000
5 NetIncome 2,834,595
6 ComprehensiveNetIncome 2,834,595
7 BaseVar 5,670,820
8 EconomicCapitalRatiobeforeLimitedLiability -2.51
9 EconomicCapitalRatio 0.850

Edgar->Model Mapping

Feature Distribution

Change over Time